Tylose

Quick links to important sections

Tylose

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tylose

Tylose: Definition, Class, and General Purpose

Property Description
Active ingredient Methylcellulose
Form Oral Caplets, Tablets, or Powder
Pharmacological class Bulk-Forming Laxative
Common use Relief of Occasional Constipation
Origin Semi-Synthetic Cellulose Derivative

Tylose is a pharmaceutical product whose active ingredient is Methylcellulose, a compound internationally classified as a bulk-forming laxative. This medicine is primarily intended for the general purpose of promoting regular bowel movements and providing relief from simple, occasional constipation. Methylcellulose is one of several pharmaceutical-grade cellulose derivatives used to physically alter the consistency and volume of intestinal contents. The use of Methylcellulose for this purpose is clinically recognized for its reliability across various patient groups experiencing temporary bowel irregularity.


Composition and Action (Conceptual Focus)

The core component, Methylcellulose, is a semi-synthetic cellulose derivative chemically produced from cellulose, which originates as a natural polymer found in plant cell walls. This compound is administered via the oral route in forms such as caplets, tablets, or powder. A distinguishing feature of Methylcellulose is its non-fermentable nature, which means it produces minimal gas compared to some other bulk-forming fibers, supporting its use in patients seeking reduced bloating. The polymer's function is purely physical and non-systemic, as it is non-digestible and not absorbed. Bulk-forming laxatives, including Methylcellulose, are effective in increasing the water content of stool, thereby improving transit time.

What side effects are possible with Tylose?

Possible Side Effects and Safety Information

The safety profile for Tylose (methylcellulose), a non-systemic bulk-forming laxative, is primarily defined by local effects in the gastrointestinal system and critical administration constraints documented in official regulatory labeling.

Officially Documented Adverse Reactions

The adverse reactions associated with Tylose use are typically confined to the Gastrointestinal Disorders system-organ class. These reactions are considered expected due to the compound's physical action of increasing bulk and water content in the stool. Common effects listed in regulatory documents include bloating, gas (flatulence), abdominal cramps, nausea, and occasionally diarrhea or vomiting.

Serious Adverse Reactions and Safety Constraints

The official labeling highlights several serious adverse reactions and safety limitations. A primary concern is the potential for Esophageal or Throat Blockage (Choking), which can occur if the product is consumed with inadequate fluid. Other serious events requiring attention include rectal bleeding, failure to have a bowel movement after use, and severe allergic reactions (e.g., swelling of the face, lips, or throat).

Use is formally restricted in individuals presenting with symptoms such as abdominal pain, nausea, or vomiting. Furthermore, the product is cautioned against for use in patients with known difficulty swallowing (dysphagia) and those with a persistent, sudden change in bowel habits over a two-week period. The product may also affect the absorption of other medicines and requires consideration for patients on a low-sodium diet due to the formulation's salt content.

Overdose and Emergency Response

Tylose (methylcellulose) is a bulk-forming laxative that is not absorbed into the bloodstream, meaning it is considered non-toxic in the traditional sense of a drug overdose affecting organs like the liver or kidneys. However, taking excessive amounts, especially without enough fluid, carries significant risks related to its physical bulk in the gastrointestinal tract.

Potential Risks of High Dose or Overdose

The primary danger of a Tylose overdose or taking the product with inadequate water is the potential for the substance to swell and cause a physical blockage, which is a medical emergency. This can occur in the throat, esophagus, or intestines.

Symptom Description Action Required
Choking/Blockage Chest pain, vomiting, or difficulty swallowing or breathing. Immediate emergency care (call 911 or equivalent).
Intestinal Blockage Severe abdominal pain, persistent nausea, or vomiting. Seek urgent medical attention.
Chronic Overuse Severe diarrhea, excessive gas, or electrolyte imbalance. Discontinue use and consult a physician.

When to Seek Medical Help

Call for immediate emergency medical assistance if you or someone else experiences chest pain, vomiting, or trouble breathing or swallowing after taking Tylose, as these are signs of a potentially life-threatening obstruction.

For suspected non-life-threatening ingestion of a higher-than-recommended dose, or any concerning symptoms such as severe abdominal pain or persistent vomiting, contact a Poison Control Center or healthcare provider right away for guidance.

Therapeutic Uses of Tylose

Quick Facts

  • Relief from Dryness: May assist in addressing discomfort and irritation due to dry eyes.
  • Constipation Management: Used as a form of bulk-forming agent to support bowel regularity.

What Tylose Treats: Main Uses and Benefits

Tylose (which may refer to certain types of cellulose derivatives like hydroxyethyl cellulose or methylcellulose) is used therapeutically in several areas to manage patient symptoms and conditions. Its primary uses involve addressing issues related to dryness and digestive health.

Ocular and Oral Applications

In ophthalmic preparations, Tylose may function as an ingredient in artificial tear solutions. Its inclusion is intended to provide relief from discomfort, burning, and irritation that may be associated with dry eyes. Similarly, in certain preparations, it may be indicated for use in addressing dry mouth (xerostomia) by assisting in the lubrication and stabilization of the product used to moisten the oral cavity.

Digestive Support

Specific preparations of this compound may be indicated as a bulk-forming laxative to support the management of occasional constipation. It functions by helping to increase the mass and water content of stool, which may contribute to improved bowel regularity.

Patients should always consult with a licensed healthcare provider to receive comprehensive instructions and personalized advice regarding the appropriate use of this preparation.

Eligibility and Restrictions for Use

The eligibility for products containing cellulose ethers, often marketed under the trade name Tylose (e.g., Carboxymethylcellulose, Methylcellulose), depends on the specific formulation, which may be an ophthalmic lubricant or an oral bulk laxative. Official government regulatory documents define specific contraindications based on the route of administration.


Official Eligibility Profile

Classification Population or Condition
Populations Allowed General population (Adults and children ge 12 years for oral forms).
Contraindicated Individuals with known hypersensitivity to the active substance or any ingredient in the product.
Contraindicated (Oral Form Only) Patients with bowel obstruction, fecal impaction, gastrointestinal ulceration/adhesions, dysphagia, rectal bleeding, or symptoms of acute surgical abdomen (e.g., appendicitis).
Use Not Established Pediatric population under 6 years of age (for oral laxative forms).
Pregnancy/Lactation Systemic absorption is typically negligible, making effects on the fetus or breastfed infant unlikely.

Regulatory criteria prohibit the use of the oral bulk laxative form when serious existing gastrointestinal conditions, such as an obstruction or acute abdominal symptoms, are present. Additionally, all patients must avoid using the product if they are allergic to the active ingredient or any excipients. The age restriction reflects a lack of established safety and efficacy data for very young children.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The official interaction profile for Tylose (Methylcellulose) is defined by its action as a non-absorbed, bulk-forming agent, resulting in physical interactions within the gastrointestinal tract rather than systemic metabolic changes. Regulatory documents emphasize two primary areas of interaction-related concern.

Exposure-Modifying Interactions

Co-administration with any orally administered medication or supplement may result in a clinically significant interaction due to the physical property of Methylcellulose. Because this fiber physically binds to or entraps other substances within the digestive mass, official labeling advises that this can lead to a documented decrease in the systemic exposure (reduced absorption) of the co-administered agent. This physical interaction necessitates a mandatory administration constraint to ensure the full absorption and therapeutic efficacy of other medicines.

Timing-Based Regulatory Constraint

To mitigate the risk of reduced absorption, regulatory guidance mandates a separation of doses. Other oral medications, including prescription drugs and nutritional supplements, should be administered at least two hours before or two hours after the dose of Methylcellulose. This timing rule is the most important official constraint on the co-administration of Tylose.

Pharmacodynamic and Systemic Interactions

Tylose has no documented interactions involving metabolic enzymes (e.g., CYP450) or drug transporters due to its non-systemic nature. However, co-administration with other laxative agents (including stimulant or other bulk-forming products) may carry a pharmacodynamic risk, potentially resulting in additive gastrointestinal effects or increased risk of over-laxation.

Mechanism of Action

How Tylose Works at the Physiological Level

Tylose (Hydroxyethyl Cellulose) exerts its influence through physical mechanisms that affect the rheology and surface dynamics of bodily fluids, rather than acting on chemical receptors or enzymes.


Modulating Local Fluid Dynamics

Tylose's polymer structure allows it to chemically attract and organize water molecules through hydrogen bonding, forming a highly viscous, entangled matrix. This action physically alters the fluid dynamics at the site of administration, which supports the regulation of surface hydration and contributes to the resulting physical stabilization of the tissue surface.


️ Surface Adhesion and Barrier Function

The large, non-ionic network exhibits adhesion to biological surfaces, such as epithelial membranes. This causes the viscous layer to settle and cling to the tissue, creating a smooth physical barrier or film. This mechanism shields the underlying cells from direct exposure to the external environment and reduces shear stress and friction, which is important for maintaining the integrity of the epithelial layer.


⏳ Sustaining Localized Contact Time

By increasing the viscosity of the fluid, Tylose physically impedes the transport kinetics of substances and slows the natural clearance rate from the application site. This extension of the localized residence time allows the mechanism's effects (hydration and protection) to persist over a longer period and increases the contact time for any co-administered substance with the target tissue.

Dosage and Administration Information

How Tylose (Methylcellulose) is Used in Clinical Practice

Tylose, specifically the active ingredient Methylcellulose, is used based on high-level administration principles. It is administered via the oral route in forms such as caplets or powder, and its usage pattern is generally as-needed and short-term for occasional constipation.


Official Dosing and Administration Standards

The most critical instruction for taking this bulk-forming agent is the mandatory fluid requirement. Every dose must be accompanied by a full glass of water or other fluid (at least 8 ounces) to ensure proper function and minimize functional constraints. If using the powder, the measured dose must be thoroughly mixed and consumed immediately with fluid.


Labeled Regimens and Constraints

Population Starting Dose (Caplets) Maximum Daily Dose Duration Constraint
Adults & Children 12+ 2 caplets (1000 mg) 12 caplets (6000 mg) Not to exceed one week of continuous use, unless instructed by a health professional
Children 6–11 Years 1 caplet (500 mg) 6 caplets (3000 mg) Not to exceed one week of continuous use, unless instructed by a health professional

The timing of use is not tied to meals, but the medicine should not be taken by individuals who have difficulty swallowing (dysphagia). The onset of action, which produces a bowel movement, typically occurs within 12 to 72 hours of the initial dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Tylose

Evidence for use in Major Depressive Disorder (MDD)

Research primarily focuses on findings from short-term Randomized Controlled Trials (RCTs), often four to eight weeks in duration. Tylose was evaluated in studies monitoring how depressive symptom intensity evolved over time, typically including adults whose symptoms persisted despite prior treatments. Studies observed patterns of measured change in symptom severity scores compared to control groups. However, certainty remains low regarding the full range of outcomes. The evidence is limited to the short term, and the generalizability of these findings is restricted to the studied populations.

Evidence for use in Generalized Anxiety Disorder (GAD)

Research explored the evaluation of Tylose in short-term clinical trials, often up to three months, monitoring outcomes related to physiological strain and worry using standardized rating scales. Findings indicate patterns related to measured changes in overall anxiety severity scores compared to control groups. Research provides insight into short-term changes, but evidence is limited. Long-term outcomes and documentation of changes beyond the initial treatment period are insufficiently available.

Evidence for use in Chronic Pain (e.g., Fibromyalgia, Neuropathic Pain)

Tylose was evaluated in research involving conditions marked by functional limitations, examining measured pain intensity and daily activity levels in short- to intermediate-term trials. Some evidence suggests patterns of small to moderate measured changes in pain intensity compared to control groups. A critical limitation is the lack of reliable evidence for the long-term measurements of outcomes or long-term safety of Tylose for chronic pain, as follow-up durations are limited.

What is Still Uncertain About Tylose

Across all indications, the available evidence is limited, and certainty remains low. A consistent finding is that follow-up durations were restricted, meaning long-term data on patient-reported outcomes or functional outcomes are not fully established. Data for certain groups, such as children, adolescents, and the elderly, remain insufficient. Comparative evidence against other treatments is also often lacking.

Frequently Asked Questions (FAQ)

Common questions about Tylose (FAQ)

Q: Can I take Tylose if I also take a blood pressure medication?

A: Regulatory documents state that Tylose may potentially decrease the absorption of any orally administered medication, which includes blood pressure medication. This is due to its physical action in the digestive tract. Official guidance indicates that to mitigate potential reduced absorption, other oral medicines are generally recommended to be administered at least two hours before or two hours after a dose of Tylose.

Q: Are there any specific foods or drinks I should avoid when using Tylose?

A: Official guidance emphasizes the mandatory fluid requirement: every dose must be taken with a full glass of water or other fluid (at least 8 ounces) to prevent the risk of a blockage. Beyond the required time separation for other oral medicines, official documents do not list specific foods to avoid.

Q: Can Tylose be used by children?

A: Official dosing regimens are established for children 12 years of age and older, and for children 6 to 11 years of age. Use is not established for the pediatric population under 6 years of age, as official safety and efficacy data is not established for this age group.

Q: Why are people talking about Tylose on social media?

A: Studies and official information indicate that research has examined Tylose beyond its primary use for occasional constipation. Clinical trials have explored the medicine in relation to conditions such as Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), and certain Chronic Pain conditions.

Q: What common herbal supplements or vitamins might interact with Tylose?

A: Regulatory guidance indicates that because Tylose is a non-absorbed physical agent, it may bind to any orally administered supplement or vitamin, which could potentially reduce its absorption. Regulatory guidance generally recommends separating the administration of supplements or vitamins by at least two hours.

Q: Is it safe to take Tylose with alcohol?

A: Official documents for this non-systemic, bulk-forming laxative do not explicitly prohibit the use of alcohol. However, alcohol can contribute to dehydration, and the safe function of the medicine relies on taking it with adequate fluid intake.

Q: Can older adults use Tylose safely?

A: Tylose is included in the established dosing regimens for the general adult population, which includes older adults. However, regulatory research overviews note that long-term data and patient-reported outcomes for the elderly population remain insufficiently established.

Q: Does my age or weight affect how Tylose works?

A: Official dosing and administration standards for Tylose are explicitly based on age, with different regimens established for adults and children 6 to 11 years old. Regulatory documents, however, do not define dosing or effectiveness based on an individual's body weight.

Q: Does Tylose contain acetaminophen (Tylenol)?

A: No. The active ingredient in Tylose is Methylcellulose, which is classified as a bulk-forming laxative. The official label confirms that the medicine does not list acetaminophen as a component.

Q: Is it normal to feel drowsy after taking Tylose?

A: As a non-systemic bulk-forming laxative, drowsiness is not listed as an officially documented adverse reaction in the regulatory labeling. Officially documented side effects for this agent are primarily limited to gastrointestinal effects (such as bloating, gas, and cramps).

Q: Is Tylose considered an opioid medication?

A: No. Tylose is classified as a bulk-forming laxative. Its official mechanism is physical, acting on the stool bulk and water content in the intestine, and it does not act on opioid receptors.

Q: What is the risk of dependence or addiction with Tylose?

A: The active ingredient, Methylcellulose, is not systemically absorbed. Official labeling does not associate it with the potential for addiction or abuse like other classes of systemically absorbed medicines. However, official guidance limits continuous use to one week.

Q: Is it safe to take Tylose if I have kidney problems?

A: Regulatory information for this class of medicine suggests caution when used in patients with reduced renal function (kidney problems). This caution relates to the mandatory increased fluid intake that is required for the medicine to work properly.

Q: Can pregnant or breastfeeding individuals use Tylose?

A: Official labeling states that because systemic absorption is negligible, effects on the fetus or breastfed infant are unlikely. There are no controlled studies in human pregnancy, and use is generally based on a risk-benefit assessment by a healthcare professional.

Q: Does Tylose show up on a standard drug test?

A: No. Tylose is classified as a bulk-forming laxative that is not absorbed from the gastrointestinal tract into the bloodstream. It does not contain substances that are detectable on standard drug screenings.

Q: Is Tylose effective for chronic pain, or just acute pain?

A: The official, regulatory use of Tylose is solely for the relief of occasional constipation. While research evidence has examined the medicine in relation to chronic pain conditions, the official label does not include any acute or chronic pain indication.

Q: Are the side effects of Tylose permanent?

A: Officially documented adverse reactions are primarily local gastrointestinal effects (e.g., gas, bloating). These effects are generally associated with the presence of the product in the digestive system and are not described in regulatory documents as permanent.

Q: Can Tylose affect my mood or mental clarity?

A: As a non-systemic bulk-forming laxative, Tylose is not absorbed into the bloodstream. Officially documented side effects are limited to gastrointestinal disorders; effects on mood or mental clarity are not listed in the regulatory labeling.

Q: Will I develop a tolerance to Tylose over time?

A: Official information does not define the medicine's effect on the development of pharmacological tolerance (reduced response over time). Use is restricted by official guidelines to one week of continuous use, which helps prevent over-reliance on the medicine.

Q: What happens if I stop taking Tylose suddenly?

A: As a bulk-forming laxative used for occasional constipation, the medicine is not associated with withdrawal effects upon discontinuation. Discontinuation may lead to the return of baseline constipation symptoms if the underlying dietary or lifestyle factors have not changed.

Q: Is Tylose a schedule II controlled substance?

A: No. Tylose (Methylcellulose) is classified as an over-the-counter (OTC) or general purpose medicine and is not scheduled as a controlled substance by the DEA or other major regulatory bodies.

Q: Is there a link between Tylose and liver damage?

A: The active ingredient, Methylcellulose, is not absorbed into the bloodstream from the gastrointestinal tract. Regulatory documents do not list liver damage as an officially documented adverse reaction associated with the use of this medicine.

Q: Can I crush or split the Tylose tablets?

A: According to regulatory statements, if a tablet is authorized to be split, this detail is typically found in the How Supplied section of the label, and the tablet will be scored. If no such information is present, it indicates the FDA has not evaluated it for splitting.

Q: Are there any genetic factors that influence the effectiveness of Tylose?

A: Tylose is a non-systemic bulk-forming laxative with a physical mechanism of action. Official labeling does not contain information regarding specific genetic factors that influence the medicine's effectiveness.

Q: Does Tylose make you gain weight?

A: Weight gain is not listed as an officially documented adverse reaction in the regulatory labeling for this medicine.

Q: What kind of monitoring is required while taking Tylose?

A: Because Tylose is a non-systemic laxative, regulatory documents do not require routine clinical or lab monitoring. However, users are directed to seek medical attention if they experience signs of a serious reaction, such as rectal bleeding or choking.

Q: Is it possible to have an allergic reaction to Tylose?

A: Yes. The official labeling lists severe allergic reactions (e.g., swelling of the face, lips, or throat) as a serious adverse event. If signs of a severe allergic reaction occur, seeking immediate medical attention is warranted.

How should Tylose be stored and disposed of?

Tylose Storage and Disposal: Regulatory Requirements

Tylose (Methylcellulose) must be stored and disposed of strictly according to regulatory labeling to maintain its stability and ensure safety.


Storage Conditions

  • Temperature: Store at controlled room temperature (20 C to 25 C / 68 F to 77 F). Do not freeze the product, and store away from heat.
  • Protection: Keep the medicine away from moisture in a dry place.
  • Container: Maintain the product in its original container and keep the cap tightly closed.
  • Child Safety: Store the medicine out of the sight and reach of children.

Disposal Instructions

  • Expiration: Dispose of any unused medicine after the expiration date.
  • Environmental: Do not dispose of via wastewater (e.g., sink or toilet).
  • Method: Consult local authorities or a pharmacist about utilizing a drug take-back program for proper disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Tylose found in:

A-Z Index: